BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15800796)

  • 1. American Chemical Society--229th National Meeting. Kinase modulators.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):283-4. PubMed ID: 15800796
    [No Abstract]   [Full Text] [Related]  

  • 2. American Chemical Society--229th National Meeting. Oncology.
    Chan D; Mackonochie M
    IDrugs; 2005 Apr; 8(4):280-2. PubMed ID: 15800795
    [No Abstract]   [Full Text] [Related]  

  • 3. American Chemical Society - 229th National Meeting: general oral and poster sessions.
    Mackonochie M; Chan D
    IDrugs; 2005 May; 8(5):392-4. PubMed ID: 15883919
    [No Abstract]   [Full Text] [Related]  

  • 4. American Chemical Society--229th National Meeting.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):277-9. PubMed ID: 15800794
    [No Abstract]   [Full Text] [Related]  

  • 5. American Chemical Society - 229th National Meeting: bench to pilot plant.
    Rotella DP
    IDrugs; 2005 May; 8(5):390-1. PubMed ID: 15883918
    [No Abstract]   [Full Text] [Related]  

  • 6. American Chemical Society--229th National Meeting. Oral and poster presentations.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):285-7. PubMed ID: 15800797
    [No Abstract]   [Full Text] [Related]  

  • 7. American Chemical Society - 229th National Meeting: carbohydrate vaccines.
    Rotella DP
    IDrugs; 2005 May; 8(5):387-9. PubMed ID: 15883917
    [No Abstract]   [Full Text] [Related]  

  • 8. Turning promiscuous kinase inhibitors into safer drugs.
    Zhang X; Crespo A; Fernández A
    Trends Biotechnol; 2008 Jun; 26(6):295-301. PubMed ID: 18403035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinase domain mutations in cancer: implications for small molecule drug design strategies.
    Bikker JA; Brooijmans N; Wissner A; Mansour TS
    J Med Chem; 2009 Mar; 52(6):1493-509. PubMed ID: 19239229
    [No Abstract]   [Full Text] [Related]  

  • 10. Foreword: American Chemical Society Division of Medicinal Chemistry. Celebrating 100 years of excellence.
    Woster PM
    J Med Chem; 2009 Dec; 52(23):7333-8. PubMed ID: 19954244
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicinal Chemistry - XXth International Symposium. Lead finding strategies and kinase selectivity.
    Rotella DP
    IDrugs; 2008 Nov; 11(11):774-8. PubMed ID: 18988116
    [No Abstract]   [Full Text] [Related]  

  • 12. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract]   [Full Text] [Related]  

  • 13. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors.
    Akritopoulou-Zanze I; Darczak D; Sarris K; Phelan KM; Huth JR; Song D; Johnson EF; Jia Y; Djuric SW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):96-9. PubMed ID: 16216502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry--29th National Symposium. Kinase inhibitors.
    Lackey K
    IDrugs; 2004 Aug; 7(8):732-5. PubMed ID: 15334305
    [No Abstract]   [Full Text] [Related]  

  • 15. American Chemical Society 232nd national meeting. 10-14 September 2006, San Francisco, CA, USA.
    Rotella D
    IDrugs; 2006 Nov; 9(11):745-7. PubMed ID: 17096288
    [No Abstract]   [Full Text] [Related]  

  • 16. Approval heralds new generation of kinase inhibitors?
    Fletcher L
    Nat Biotechnol; 2001 Jul; 19(7):599-600. PubMed ID: 11433254
    [No Abstract]   [Full Text] [Related]  

  • 17. American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 1. 16-20 August 2009, Washington DC, USA.
    Gater D; Macauley D
    IDrugs; 2009 Oct; 12(10):605-7. PubMed ID: 19790004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 2. 16-20 August 2009, Washington DC, USA.
    Gater D; Macauley D
    IDrugs; 2009 Oct; 12(10):608-11. PubMed ID: 19790005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors.
    Loudni L; Roche J; Potiron V; Clarhaut J; Bachmann C; Gesson JP; Tranoy-Opalinski I
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4819-23. PubMed ID: 17624773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Chemical Society--238th National Meeting & Exposition. Novel small molecule therapeutics. 16-20 August 2009, Washington DC, USA.
    Rotella DP
    IDrugs; 2009 Oct; 12(10):612-3. PubMed ID: 19790006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.